Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Hepatic cell-type specific gene expression better predicts HCV treatment outcome than IL28B genotype.
McGilvray I, Feld JJ, Chen L, Pattullo V, Guindi M, Fischer S, Borozan I, Xie G, Selzner N, Heathcote EJ, Siminovitch K.
Gastroenterology. 2012 May;142(5):1122-1131.e1. Epub 2012 Jan 25.
Related citations
Hepatic mass in a 73-year-old man.
Hechtman JF, Raoufi M, Fiel MI.
Gastroenterology. 2012 Mar;142(3):434, 679. Epub 2012 Jan 26. No abstract available.
Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1.
Lee CG, Kim YW, Kim EH, Meng Z, Huang W, Hwang SJ, Kim SG.
Gastroenterology. 2012 May;142(5):1206-1217.e7. Epub 2012 Jan 18.
HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons.
Thomas E, Gonzalez VD, Li Q, Modi AA, Chen W, Noureddin M, Rotman Y, Liang TJ.
Gastroenterology. 2012 Apr;142(4):978-88. Epub 2012 Jan 13.
Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues.
Hernández-Gea V, Ghiassi-Nejad Z, Rozenfeld R, Gordon R, Fiel MI, Yue Z, Czaja MJ, Friedman SL.
Gastroenterology. 2012 Apr;142(4):938-46. Epub 2012 Jan 10.
Estrogen receptor α represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4α.
Wang SH, Yeh SH, Lin WH, Yeh KH, Yuan Q, Xia NS, Chen DS, Chen PJ.
Gastroenterology. 2012 Apr;142(4):989-998.e4. Epub 2012 Jan 10.
Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival.
Roessler S, Long EL, Budhu A, Chen Y, Zhao X, Ji J, Walker R, Jia HL, Ye QH, Qin LX, Tang ZY, He P, Hunter KW, Thorgeirsson SS, Meltzer PS, Wang XW.
Gastroenterology. 2012 Apr;142(4):957-966.e12. Epub 2011 Dec 24.
Fibronectin extra domain-A promotes hepatic stellate cell motility but not differentiation into myofibroblasts.
Olsen AL, Sackey BK, Marcinkiewicz C, Boettiger D, Wells RG.
Gastroenterology. 2012 Apr;142(4):928-937.e3. Epub 2011 Dec 24.
Transient ischemic attack in a patient with cirrhosis.
Mathur J, Limsui D.
Gastroenterology. 2012 Feb;142(2):e14-5. Epub 2011 Dec 21. No abstract available.
Noninvasive parameters for predicting esophageal varices in children: their sequential use provides the best accuracy.
Colecchia A, Festi D, di Biase AR.
Gastroenterology. 2012 Feb;142(2):e32; author reply e32-3. Epub 2011 Dec 17. No abstract available.
Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats.
Xie G, Wang X, Wang L, Wang L, Atkinson RD, Kanel GC, Gaarde WA, Deleve LD.
Gastroenterology. 2012 Apr;142(4):918-927.e6. Epub 2011 Dec 16.
Protein engineered variants of hepatocyte growth factor/scatter factor promote proliferation of primary human hepatocytes and in rodent liver.
Ross J, Gherardi E, Mallorqui-Fernandez N, Bocci M, Sobkowicz A, Rees M, Rowe A, Ellmerich S, Massie I, Soeda J, Selden C, Hodgson H.
Gastroenterology. 2012 Apr;142(4):897-906. Epub 2011 Dec 13.
Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease.
Masyuk TV, Radtke BN, Stroope AJ, Banales JM, Masyuk AI, Gradilone SA, Gajdos GB, Chandok N, Bakeberg JL, Ward CJ, Ritman EL, Kiyokawa H, LaRusso NF.
Gastroenterology. 2012 Mar;142(3):622-633.e4. Epub 2011 Dec 7.
Direct and indirect contribution of human embryonic stem cell-derived hepatocyte-like cells to liver repair in mice.
Woo DH, Kim SK, Lim HJ, Heo J, Park HS, Kang GY, Kim SE, You HJ, Hoeppner DJ, Kim Y, Kwon H, Choi TH, Lee JH, Hong SH, Song KW, Ahn EK, Chenoweth JG, Tesar PJ, McKay RD, Kim JH.
Gastroenterology. 2012 Mar;142(3):602-11. Epub 2011 Dec 2.
Frequent aneuploidy among normal human hepatocytes.
Duncan AW, Hanlon Newell AE, Smith L, Wilson EM, Olson SB, Thayer MJ, Strom SC, Grompe M.
Gastroenterology. 2012 Jan;142(1):25-8. Epub 2011 Nov 2.
Alcoholic liver disease: pathogenesis and new therapeutic targets.
Gao B, Bataller R.
Gastroenterology. 2011 Nov;141(5):1572-85. Epub 2011 Sep 12. Review.
Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment.
Talwalkar JA, Swanson KL, Krowka MJ, Andrews JC, Kamath PS.
Gastroenterology. 2011 Nov;141(5):1673-9. Epub 2011 Jun 30.
A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
Teratani T, Tomita K, Suzuki T, Oshikawa T, Yokoyama H, Shimamura K, Tominaga S, Hiroi S, Irie R, Okada Y, Kurihara C, Ebinuma H, Saito H, Hokari R, Sugiyama K, Kanai T, Miura S, Hibi T.
Gastroenterology. 2012 Jan;142(1):152-164.e10. Epub 2011 Oct 10.
Chelation therapy for secondary iron overload: is the primary effect less iron or less liver fibrosis?
Adams PC.
Gastroenterology. 2011 Oct;141(4):1142-3. Epub 2011 Aug 24. No abstract available.
RB and p53 cooperate to prevent liver tumorigenesis in response to tissue damage.
McClendon AK, Dean JL, Ertel A, Fu Z, Rivadeneira DB, Reed CA, Bourgo RJ, Witkiewicz A, Addya S, Mayhew CN, Grimes HL, Fortina P, Knudsen ES.
Gastroenterology. 2011 Oct;141(4):1439-50. Epub 2011 Jun 24.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on